By using nano‐curcumin in COVID‐19 patients, although it did not have a significant effect on CRP, hs‐CRP, and IL‐6, it decreased the gene expression of IL‐6 (Shojaei, Foshati, et al., 2023). The gene discussed is MAP3K14; the disease is COVID-19.